The PUFA Investigation: An Expert Interview

Linda Brookes, MSc; Christopher E. Ramsden, MD

Disclosures

March 18, 2013

In This Article

A Best Evidence Interview With Christopher E. Ramsden, MD

About the Interviewee

Christopher E. Ramsden, MD, is a clinical investigator in theLaboratory of Membrane Biophysics and Biochemistry at the National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland. He is a Lieutenant Commander in the US Public Health Service. He also acts as an adjunct assistant professor at the University of North Carolina-Chapel Hill, North Carolina.

Dr. Ramsden's research is directed toward conducting diet intervention trials to address evidence gaps in the field. He has been principal investigator on collaborative human trials that are focused on the biochemical and clinical effects of altering dietary omega-6 and omega-3 fatty acids. He is also involved in animal and in vitro studies evaluating the bioactivities of fatty acid metabolites.

The Study

Dr. Ramsden was principal investigator and lead author of:

Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis. BMJ. 2013;346:f903.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as:

processing....